TimePie (focus on anti-aging science)
@TimePieChina
@TimePieChina focuses on aging science & longevity news. We would love to be the bridge to academic circle of aging in China. #aging #longevity #senescence
The 6th #TimePieLongevityForum, September 20-21 Shanghai, China 🔥 For more information: timepielongevityforum.com
How do we bring #Geroscience to the clinic? Dr. Evelyne Bischof (@Dr_Bischof) spotlighted real-world progress in healthy #longevity medicine—with a special case, Sheba Medical Center (@sheba_medical), at the 5th #TimepieLongevityForum. Learn more: youtube.com/watch?v=zQtmCh…
Scientists of @gladyshev_lab developed a new probabilistic aging model, #LongReadAge, capable of predicting epigenetic age at the cell type level, despite limited shared features across samples. By Alec Eames, @mahdi_moqri, Vadim N. Gladyshev, et al. doi.org/10.1111/acel.7…
From Neuroscience into #Longevity. @KlothoNeuroSci is making a pivot to expand beyond its original neurology focus into broader longevity applications, pursuing technologies targeting muscle strength, bone health & longevity indicators. stocktitan.net/news/KLTO/klot…
We are honored to welcome Dr. Jan Vijg from @EinsteinMed as our speaker at #TimepieLongevityForum2025! Dr. Jan Vijg was the first to develop transgenic mouse models to study somatic mutations, including #MutaMouse—now an industry standard in genetic toxicology.
What supplements do China’s centenarians take? 🧓 In a survey of ~3,000 participants (#CLHLS), 10.7% of women & 12.3% of men reported using dietary supplements—calcium and protein were most common. By @Jozo_Grgic, @BradSchoenfeld, et al. link.springer.com/article/10.100…
🌍 A Global First in #GeneEditing! 🇨🇳 Shanghai’s BDGENE has completed clinical dosing of the world’s first in vivo #CRISPR gene-editing therapy for a viral disease—moving closer to regulatory approval and market launch. bdgenetherapeutics.com/en/ Source：bydrug.pharmcube.com/news/detail/de…
NMN-Loaded Vesicles Delay Skin #Aging New research reveals that small vesicles derived from human umbilical cord cells, when infused with #NMN, delay skin aging in a mouse model. #NAD #sEVs stemcellres.biomedcentral.com/articles/10.11…
The "Power Duo" in #GeneEditing! 🇨🇳Shanghai-based BASE Therapeutics x @Synthego team up to bring AccuBase® base editors to the global stage—unlocking new frontiers by breaking #CRISPR boundaries. Source: bydrug.pharmcube.com/news/detail/35… More on BASE: basetherapeutics.com/indexcn.html
72 participants enrolled—@QuBiologics is set to launch its Phase 2 trial, evaluating the ability of its first-in-class immunomodulator QBKPN SSI to restore innate #immunity in adults aged 65 and older. globenewswire.com/news-release/2…
#COVID-19 sped up brain #aging—even without infection! @NIHRresearch scientists find people who lived through COVID—without infection—show signs of accelerated brain aging, especially older adults, men & those from disadvantaged backgrounds. nature.com/articles/s4146…
We are thrilled to welcome Prof. Andrei Seluanov from @UofR back to #TimepieLongevityForum2025 as a speaker! His research explores mechanisms of #longevity and genome stability, with a focus on long-lived, cancer-resistant mammals.
$2.1B+ Deal: Chinese Cell Therapy Goes Global! 🇨🇳 Novatim Immune Therapeutics (en.novatim-zj.com) inks $2.1B+ licensing deal with US-based #ERIGEN, granting ex-China rights to its cell therapy KQ-2003—marking a major milestone in global expansion. 21jingji.com/article/202507…
Integrated Longevity care heads to Southeast Europe. Blue Longevity raises €2M to scale its integrated, lifestyle-based #longevity clinics to Athens, Istanbul & Sofia. #healthspan longevity.technology/news/blue-long…
🧬 Klotho x AAVnerGene: Powering Next-Gen Longevity Gene Therapies @KlothoNeuroSci teams up with @aavnergene to accelerate gene therapies for Alzheimer’s, ALS & #aging—promising faster, cheaper, and safer #AAV delivery with cutting-edge targeting tech. prnewswire.com/news-releases/…
Global Team-Up to Rejuvenate Cells🔬 Life Biosciences (@lifebiosciences) just announced a partnership with REMEDIS of SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (@dukenus) to expand pipeline of cellular rejuvenation therapies. globenewswire.com/news-release/2…
"if this works, nobody will catch up" John G Cramer, Physicist, 90, joins experimental trial to challenge age limits. He will be the first human recipient of bioreactor-grown mitochondria in an early-stage #longevity study led by Mitrix Bio(@PathfinderEq). longevity.technology/news/physicist…
Physician-led health tech startup @MDLifespan scales Therapeutic Plasma Exchange (#TPE) nationwide in USA amid rise in diseases linked to toxins. prnewswire.com/news-releases/…
